The MVC COVID-19 vaccine (Chinese: 高端新冠肺炎疫苗; pinyin: Gāoduān xīnguàn fèiyán yìmiáo; Wade–Giles: Kaotuan hsinkuan feiyen imiao), designated MVC-COV1901 and...
15 KB (1,455 words) - 06:02, 24 September 2024
vaccines of this type include the peptide vaccine EpiVacCorona, ZF2001, MVC-COV1901, Corbevax, the Sanofi–GSK vaccine, and Soberana 02 (a conjugate vaccine)...
202 KB (23,026 words) - 19:12, 2 November 2024
(2) China Indonesia Travel-only Hong Kong Malaysia New Zealand Turkey MVC-COV1901, is a protein subunit vaccine developed by Taiwan's Medigen Vaccine Biologics...
322 KB (19,558 words) - 03:33, 16 September 2024
subunit vaccines: Abdala, Corbevax, COVAX-19, EpiVacCorona, IndoVac, MVC-COV1901, Noora, Novavax, Razi Cov Pars, Sanofi–GSK, Sinopharm CNBG, Skycovione...
95 KB (18,965 words) - 23:35, 15 September 2024
Moderna United States phase III clinical trials 5 May 2021 9 June 2021 MVC-COV1901 Medigen Vaccine Biologics Corporation Taiwan phase II clinical trials...
76 KB (6,546 words) - 20:42, 16 May 2024